Screener
Actinium Pharmaceuticals ATNM Q2 2025 earnings
Reported August 8, 2025 · Before market open
EPS-$0.22Beat by $0.10
EPS estimate-$0.32
Next report
Nov 13, 2026 (in 2 months)Revenue estimate$1.2M
EPS estimate-$0.25
Versus estimates
Diluted EPS
FAQ
- When did Actinium Pharmaceuticals report Q2 2025 earnings?
- Actinium Pharmaceuticals (ATNM) reported Q2 2025 earnings on August 8, 2025 before market open.
- What were Actinium Pharmaceuticals's Q2 2025 revenue and EPS?
- Actinium Pharmaceuticals reported eps of $-0.22 for Q2 2025.
- Did Actinium Pharmaceuticals beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.32 by $0.10.
- How did Actinium Pharmaceuticals's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 42.1% from $-0.38.
- Where can I find Actinium Pharmaceuticals's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001213900-25-073743) directly on SEC EDGAR. The filing index links above go to sec.gov.
